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Abstract 
Purpose: To investigate the antibacterial activity of extracts from Catunaregam tomentosa on Bacillus 
subtilis and Staphylococcus aureus, and the bacterial responses to the extracts. 
Methods: The antibacterial activity of fruit, leaf and stem bark extracts were evaluated against B. 
subtilis (ATCC6633) and S. aureus (ATCC25923). Using a disc diffusion method, extracts at 
concentrations ranging from 50 – 1,000 µg/disc were tested. The minimum inhibitory (MIC) and 
minimum bactericidal concentrations (MBC) of the extracts against the test bacteria were determined. 
Fluorescent activated cell sorting (FACS) was used to assess the responses of both types of bacteria to 
the extracts. 
Results: The fruit and leaf extracts at 1,000 µg/disc showed optimum efficacy against B. subtilis and S. 
aureus with MIC of 1,000 µg/mL against both B. subtilis and S. aureus, for the fruit and the leaf extracts. 
With increasing doses of fruit and leaf extracts at 6 h of incubation, FACS profiles revealed that cell 
death for B. subtilis increased. The fruit and leaf extracts of C. tomentosa also exhibited antibacterial 
activity against S. aureus in a dose- and time-dependent manner. The bacteria initially lost their 
granularity, then lost membrane integrity, and consequently died. 
Conclusion: The fruit and leaf extracts of C. tomentosa exhibit significant antibacterial potential against 
Gram-positive bacteria by damaging bacterial granularity and membrane integrity.  
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In recent years multidrug-resistant (MDR) 
pathogenic bacteria have been increasingly 
reported, largely due to a history of indiscriminate 
use of various antibiotics. This process selects 
for the resistant strains, killing off the competing 
non-resistant bacterial population. MDR strains 
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are therefore common in connection with 
infections, such as gastritis, urinary tract 
infections, encephalitis, and food poisoning [1,2]. 
In addition, in 2014, the World Health 
Organization reported that MDR strains are now 
a major threat to public health, as no antibiotic 
has efficacy against them.  
 
Thus, it is necessary to search for novel 
alternatives, using plant and animal natural 
products as potential sources of antibacterial 
drugs. Traditional medicine tends to rely on 
medicinal herbal plants, and such medicinal 
plants may provide novel phytochemicals to use 
as bactericides [3]. The use of medicinal herbal 
plants has been promoted as effective against 
infectious diseases, but with fewer side effects 
than synthetic drugs.  
 
Many plant families are of current interest in 
medicinal research. Interestingly, various parts of 
the plants in the genus Rubiaceae have been 
reported to have significant antibacterial 
efficacies [4,5]. For instance, the roots of 
Catunaregam tomentosa reportedly have 
antibacterial properties against some Gram 
positive bacteria [6]. In traditional medicine, the 
roots of C. tomentosa have been used by healers 
for stomatitis and ulcer therapies. However, in 
Thai traditional medicine, while the roots of this 
plant are designated for treating infectious 
symptoms and in vivo for antibacterial effects, 
the aerial parts of the plant, such as fruit, leaf, 
and stem bark, have not been measured for their 
potential bioactive activity.  
 
In the present study, we tested the activities of C. 
tomentosa fruit, leaf, and stem bark extracts 
against Bacillus subtilis and Staphylococcus 
aureus, and assessed the bacterial population 




Plant materials and extract preparation 
 
Fresh plant tissue samples (fruit, leaf, and stem 
bark) were collected from 10-year old C. 
tomentosa from the Chaiya District, Suratthani 
Province, Thailand. The samples were washed 
separately under running tap water and dried. 
Each dried sample (125 g) was soaked in 99% 
methanol for 5 days, and the suspension was 
filtered with two cotton layers. The methanolic 
filtrate was concentrated in a rotary evaporator at 
45 ºC until a sticky mass was obtained. The 
sticky mass was weighed and then stored at 4 ºC 
until further use. These constituted the three 
concentrated extracts, representing fruit, leaf, 
and stem bark. 
Test microorganisms 
 
The bacterial strains tested for antimicrobial 
activity by C. tomentosa extracts were B. subtilis 
(ATCC6633), and S. aureus (ATCC25923). The 
bacterial strains were obtained by and 
maintained at the Scientific Laboratory and 
Equipment Center, Prince of Songkla University, 
Surat Thani campus, Thailand.  
 
The bacterial strains were cultured on nutrient 
agar (NA) plates and incubated for 18 to 24 h at 
37 ºC. A single colony was then cultured in 50 
mL nutrient broth (NB) for 4 h at 37 ºC. The 
turbidity of the bacterial culture required for the 
tests was adapted to 0.5 McFarland standard, 
(1.0 × 107 colony forming units/mL) and was 
measured with a spectrophotometer (Thermo 
Fisher Scientific, Madison, WI, USA). 
 
Disc diffusion assay 
 
Antibacterial activities of the extracts were 
estimated by the disc diffusion method on 
trypticase soy agar. Sterile cotton swabs were 
dipped into the bacterial strain suspension (at 1 × 
107 CFU/mL) and used to uniformly inoculate the 
whole surface of an agar plate. Filter paper discs 
(6 mm diameter) were used to absorb 25 µL of 
an extract in aqueous solution, at concentrations 
that gave 50, 100, 250, 500, or 1,000 µg/disc of 
the extract. The discs were air dried and placed 
on the inoculated agar. The agar plates were 
then incubated for 24 h at 37 ºC. The standard 
antibiotic disc (positive control) had 
oxytetracycline (OTC) at 30 µg/disc, and the 
negative control discs contained 10% dimethyl 
sulfoxide (DMSO). 
 
Determination of minimum inhibitory (MIC) 
and minimum bactericidal concentrations 
(MBC)  
 
MIC was determined for each type of plant 
extract that gave clearly positive results in the 
disc diffusion test. The determination used two-
fold serial dilutions, with extract concentrations of 
1,000, 500, 250, 125, 62.5, 31.25, 15.62, 7.81, 
3.90, and 1.95 µg/mL. One mL of extract solution 
was added to the first tube containing 1 mL of 
sterile trypticase soy broth with 1 × 107 CFU/mL 
bacteria, resulting in a final concentration of 
extract of 1,000 µg/mL. Then, 1 mL of this 
solution was transferred to the next tube 
containing 1 mL of 1 × 107 CFU/mL bacteria, for 
a two-fold dilution.  
 
These steps were repeated nine times to create 
the dilution series. DMSO served as the negative 
control, and the positive control was 
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oxytetracycline at 30 µg/mL. The culture was 
incubated at 37 ºC for 24 h. The MIC was 
determined as the final dilution of extract that 
showed growth inhibition of the microorganisms. 
The MBC was determined after the MIC 
determination. The cultures in the tubes that 
showed no turbidity were each spread on an NA 
plate. The plates were incubated overnight at 37 
ºC, and the lowest concentration without 
bacterial growth was recorded as the MBC. 
 
Fluorescent activated cell sorting (FACS) 
analysis 
 
Bacterial strains were grown to the mid-
logarithmic phase (1 × 107 CFU/mL), and then 
the cultures were harvested and 1 mL of each 
bacterial strain was placed in a microcentrifuge 
tube. Each sample was centrifuged at 8,000 rpm 
for 10 min, and then the extracts were added at 
concentrations of 0.5 × MIC, 1 × MIC, and 2 × 
MIC. While exposed to a range of extract 
concentrations, the bacteria were incubated at 37 
ºC for 3 h and 6 h. After incubation, the samples 
were centrifuged at 8,000 rpm for 10 min, and 
then washed twice with 950 µL phosphate-
buffered saline. Each sample was mixed with 
propidium iodide (PI; 30 µg/mL) and incubated 
for 15 min at room temperature in darkness, 
before testing with flow cytometry.  
 
Flow cytometry procedures and interpretations of 
the FACS profiles followed previously published 
methods [7]. Briefly, when a density plot of the 
cell population was made in the PI and side 
scatter (SSC) quadrants, the treated cells were 
labeled according to their quadrant: lower left 
represented viable cells (PI-, SSC-), lower right 
represented membrane-damaged cells (PI+, 
SSC-), upper left represented injured cells (PI-, 
SSC+), and upper right represented dead cells 
(PI+, SSC+). The transition from healthy viable 
bacteria to those killed by a treatment was 
assessed from the FACS data. The percentage 
of dead bacteria were also counted and 
compared between alternative treatments. 
 
Statistical analysis  
 
The data are presented as mean ± SD and were 
analyzed by analysis of variance (ANOVA). 
Comparisons of the means between treatments 
were performed using the Duncan’s Multiple 
Range test. P < 0.05 was considered statistically 
significant. The data obtained from antibacterial 
studies were analyzed using SPSS statistical 







The antimicrobial activities of C. tomentosa fruit, 
leaf, and stem bark extracts were studied with 
two types of Gram positive bacteria. The extract 
exhibited antibacterial properties as shown in 
Table 1. The zones of inhibition by the leaf 
extract against B. subtilis and S. aureus were 
from 8.0 mm‒12.67 mm, and the 1,000 µg/disc 
dose was the most effective. The maximal 
inhibition zones were observed with the fruit 
extract of C. tomentosa at 1,000 µg/disc, these 
being 12.23 mm with B. subtilis and 12.17 mm 
with S. aureus. Thus, both types of bacteria were 
sensitive to the fruit and the leaf extracts of C. 
tomentosa. However, the stem bark extract did 
not exhibit antibacterial activity against the tested 
bacteria. Therefore, only the fruit and leaf 
extracts were used in subsequent experiments. 
 





Diameter of zone of inhibition (mm) 



























50  - - - - - - 
100  - 8±1.0d - - - - 
250  - 10.33±0.57c - - 9.33±0.58c - 
500  11±2.65b 11.67±0.57bc - 11.17±0.29c 10±1.0b - 
1,000  12.23±0.57b 12.67±0.57b - 12.17±0.29b 12±0.5b - 
10% DMSO - - - - - - 
Susceptibility  Sensitive Sensitive Resistant Sensitive Sensitive Resistant 
The zone of inhibition was converted to susceptibility rating as follows: resistant, ≤6 mm; susceptible, sensitive, 
≥12 mm. Values followed by the same superscript letter in a column did not differ statistically significantly 
(significance means p < 0.05); TC = oxytetracycline; DMSO = dimethyl sulfoxide 
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Table 2: Minimum inhibitory (MIC) and minimum 
bactericidal concentration (MBC) for Catunaregam 

















Fruit  1,000 nd 1,000 nd 
Leaf  1,000 nd 1,000 nd 
Nd = not detectable 
 
Minimum inhibitory and minimum bactericidal 
concentrations 
 
As shown in Table 2, it was found that the two 
bacterial strains tested (B. subtilis and S. aureus) 
were sensitive to both extracts, and the MIC 
values of these extracts were 1,000 µg/mL. 
Unfortunately, the extracts did not inhibit the 
growth of bacteria in testing for MBC, so no MBC 
values were determined. 
 
Membrane granularity and integrity 
 
Actions of the C. tomentosa extracts on bacterial 
populations, in terms of indicators of granularity 
and membrane permeability, were investigated 
from FACS profiles. Flow cytometric profiles, 
using PI staining to obtain one coordinate and 
side scatter as the other coordinate, are shown in 
Figures 1–4. The C. tomentosa extracts were 
used at various concentrations and various 
exposure times. The results showed that both 
bacterial strains responded to treatment by the 
C. tomentosa extracts (Table 3 and Table 4). At 
3 h of incubation with extract from the leaves of 
C. tomentosa, as the extract concentration 
increased (0.5 × MIC to 1 × MIC to 2 × MIC), the 
bacterial population continuously showed 
changes. First, granularity was lost, followed by 
loss of membrane permeability, resulting in 3.9 to 
16.4 to 25.7 % death rates of B. subtilis, and 2.7 
to 5.5 to 21.0 % death rates of S. aureus at the 
three MICs, respectively. When the exposure 
time was 6 h, the B. subtilis and S. aureus 
populations again responded continuously (2.1 to 
11.5 to 20.5 % death rates, and 8.2 to 11.7 to 
34.1 % death rates, respectively, for the MICs). 
S. aureus responded to the leaf extract in a 
manner dependent on the dose and exposure 
times, whereas B. subtilis responded in a dose-
dependent manner with little effect from various 
exposure times. On treatment with the fruit 
extract of C. tomentosa, increasing the doses 
from 0.5 × MIC to 1 × MIC to 2 × MIC induced B. 
subtilis death both at 3 h and 6 h of incubation 
(1.2 to 4.8 to 21.5 %, and 1.6 to 3.2 to 20.1 %, 
respectively), whereas continuous responses 
involving the mortality of S. aureus were 
observed at 6 h of incubation (23.7 to 25.2 to 
45.7 %, for the three MICs, respectively). Both 
bacterial strains responded to fruit extracts in a 
dose-dependent manner. The patterns of 
bacterial response were identified as follows: 
Injured cells (lost granularity) and dead cells 
(cells that initially lost granularity followed by lost 
membrane permeability) could be seen in the 
upper left quadrant (PI-negative, SSC-positive) 
and in the upper right quadrant (PI-positive, 
SSC-positive), respectively, whereas cells that 
lost membrane permeability were positioned in 




Figure 1: Propidium iodide (PI) staining density plot 
for the Staphylococcus aureus population treated with 
a leaf extract of Catunaregam tomentosa for 3 h and 6 
h. MIC, minimum inhibitory concentration. Double 
negative cells indicate live cell population, PI (or FL2-
A) positive cells indicate the membrane-damaged 
population, Side scatter (SSC) positive cells indicate 
the lost-granularity population and double positive 




Figure 2: PI staining density plot for the S. aureus 
population treated with a fruit extract of C. tomentosa 
for 3 h and 6 h. Abbreviations and description of all 
panels are given in Figure 1 legend 
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0 h 3 h 6 h 




























Membrane-damaged  - 0.9 1.9 3.9 8.1 5.5 6.3 1.7 
Injured (lost granularity) - 4.6 16.1 21.3 15.9 25.3 18.4 22.5 
Dead  0.1 0.3 2.7 5.5 21 8.2 11.7 34.1 
Total responders       0.1 5.8 20.7 30.7  45 39 36.4 58.3 
 
Fruit extracts 
Non-responder (viable) 97.5 96.9 34.4 33.1 29.3 29.7 41.7 30.2 
Membrane-damaged  1.7 0.6 20.6 44.5 30 44.4 31.3 21.1 
Injured (lost granularity) 0.3 0.2 3.1 2 2.1 2.3 2 3.1 
Dead  2.5 3.1 41.7 20.5 38.7 23.7 25.2 45.7 
Total responders 0.1 5.8 65.4 67 70.8 70.4 58.5 69.9 
MIC = minimum inhibitory concentration; OTC = oxytetracycline 
 




0 h 3 h 6 h 




























Membrane-damaged  18 3.8 20.3 32.1 9.7 20.8 18.8 8.8 
Injured (lost granularity) 0.4 0.3 2.1 6.2 27.7 1.2 9.4 24.6 
Dead  1.3 0.3 3.9 16.4 25.7 2.1 11.5 20.5 
Total responders  19.7 4.4 26.3 54.7 63.1 24.1 39.7 53.9 
 
Fruit extracts 
Non-responder (viable) 62.9.3 58.2 78.7 59.6 39.8 65.5 67.2 45.5 
Membrane-damaged  18 20.9 19.7 34.8 34.8 32.4 29.1 31.1 
Injured (lost granularity) 9.8 10.6 0.4 0.8 4 0.5 0.5 3.3 
Dead  8.7 10.3 1.2 4.8 21.5 1.6 3.2 20.1 
Total responders  19.7 4.4 21.3 40.4 60.3 34.5 32.8 54.5 
MIC = minimum inhibitory concentration; OTC = oxytetracycline 
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Figure 3: PI staining density plot for B. subtilis 
population treated with leaf extracts of C. tomentosa 
for 3 h and 6 h. Abbreviations and description of all 




Figure 4: PI staining density plot for B. subtilis 
populations treated with a fruit extracts of C. 
tomentosa for 3 h and 6 h. Abbreviations and 




In this study, the leaf and fruit extracts of C. 
tomentosa displayed upper-moderate to strong 
antibacterial activities. The inhibition zones of 
bacteria exposed to C. tomentosa extracts 
indicated that these extracts inhibited the growth 
of B. subtilis and S. aureus. Extract doses of 500 
– 1,000 µg/disc gave satisfactory clear zone 
sizes (8 ‒ 12 mm). Although C. tomentosa has 
earlier been reported by Wutithamawech et al [6] 
as a treatment for bacterial infectious symptoms 
used as a root extract, the root extract did not 
inhibit the growth of S. aureus that was resistant 
to the extract.  
 
However, in our study, significant differences 
were observed between extracts from various C. 
tomentosa plant tissues, which had antibacterial 
activities against B. subtilis and S. aureus. The 
results suggested that B. subtilis and S. aureus 
were susceptible to fruit and leaf extracts of C. 
tomentosa at 500 ‒ 1,000 µg/disc. Thus, this is 
the first time that the antibacterial activity of C. 
tomentosa has been documented by direct 
observations of bacterial populations. The leaf 
extract was more potent against B. subtilis than 
the fruit extract, whereas the extract activities 
against S. aureus had the reverse order. 
Unfortunately, a stem bark extract of C. 
tomentosa did not exhibit any antibacterial 
activity in the current study. The root of this plant 
has been prescribed in Thai traditional medicine 
to treat infectious diseases such as stomatitis 
and ulcer [6], but the current study is the first to 
report the efficacy of fruit and leaf extracts 
against the growth of pathogenic bacteria. 
 
Medicinal plants have been traditionally used for 
the treatment of diseases caused by 
microorganisms, and the extracts and bioactive 
compounds from medicinal plants target a wide 
range of infections in holistic health care. 
Research on plant-derived substances, which 
confirmed their activities and determined their 
specific mechanisms of action against 
pathogenic organisms, has been widely pursued 
[8,9]. In the current study, the response patterns 
of bacterial populations to plant extracts showed 
changes in granularity and membrane 
permeability. Time and dose dependence of the 
responses were assessed, to clarify how the C. 
tomentosa extracts inhibited the growth of these 
pathogenic bacteria. We observed the bacterial 
death rates and the changes in granularity and 
membrane permeability using FACS.  
 
FACS profiles showed that both extracts were 
active against bacteria, with consistent trends in 
the death rates. The granularity of the bacteria 
was lost and the bacterial membranes were 
damaged by the tested treatments. Most studies 
have suggested that plant extracts inhibited the 
growth of bacteria by damaging the cell wall and 
the cell membrane, thus increasing membrane 
permeability and causing death of the bacteria 
[8-10]. By using FACS, we found that increasing 
the extract dose caused further loss of 
granularity, and of intracellular functions, 
subsequently inducing cell membrane injuries, 
and eventually leading to cell death. Although the 
outer membrane of a bacterium plays an 
important role in protecting the cell, permeability 
of the membrane of Gram positive bacteria could 
allow a drug to infiltrate into the cell without its 
disruption [11].  
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Thus, because the cell first lost granularity, the 
plant extracts might have played an important 
role as DNA-damaging agents that were able to 
penetrate through the cell membrane, and 
subsequently induce activation of autolysis-
induced proteins (i.e., autolysin). The action of 
autolysin could cause membrane digestion 
leading to death, indicating programmed death of 
the bacteria [12]. The patterns of bacterial 
responses to plant extracts have been explored 
in recent years, and in one study [10], the cell 
integrity was lost followed by cytoplasmic content 
leaking out of the cells and nuclear areas.  
 
However, the mechanisms observed in our 
current study included changes to granularity and 
membrane permeability, so that the C. 
tomentosa extracts might act by inducing 
programmed death in the targeted bacteria. The 
population of injured cells may be crucial if cell 
recovery becomes possible [13], as in the 
development of microbial resistance. 
 
Description of the mode of the action of these 
extracts could stimulate the search for new 
antibiotics and the exploration of programmed 
cell death pathways in bacteria. Multiple 
mechanisms may be involved, such as loss of 
granularity and damage to the cell membrane. 
This is the first report documenting both 
intracellular changes and outer membrane loss in 
bacteria exposed to plant extracts. Because the 
physiological roles of genes involved in 
programmed cell death are not precisely known 
for the tested bacteria, the proteins involved in 
the pathways of bacterial death could be studied 
in further experiments for a more detailed 
understanding of how they are involved in the 




C. tomentosa extracts are potential sources of 
antibacterial agents against various pathogenic 
bacteria. The antibacterial effects of the extracts 
include programmed death of bacteria, starting 
with granularity changes and DNA damage 
(injured cells), followed by permeability changes 
in membranes (membrane-damaged cells), and 
eventually leading to death. Programmed cell 
death-mediated proteins should be investigated 
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